Search

Your search keyword '"MESH: Anti-Infective Agents"' showing total 81 results

Search Constraints

Start Over You searched for: Descriptor "MESH: Anti-Infective Agents" Remove constraint Descriptor: "MESH: Anti-Infective Agents"
81 results on '"MESH: Anti-Infective Agents"'

Search Results

1. The Reductive Dehydroxylation Catalyzed by IspH, a Source of Inspiration for the Development of Novel Anti-Infectives

2. Editorial: Infectious Agent-Induced Chronic Immune Activation: Causes, Phenotypes, and Consequences

3. Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases

4. Selective Targeting of Human and Animal Pathogens of the Helicobacter Genus by Flavodoxin Inhibitors: Efficacy, Synergy, Resistance and Mechanistic Studies

5. Risk factors for the abundance of antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) in pig and broiler faeces in nine European countries

6. The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome

7. Revisiting the cardiovascular risk of hydroxychloroquine in RA

8. L’antibiothérapie est-elle différée selon les recommandations dans les infections urinaires de l'adulte en ambulatoire ? Étude prospective auprès des médecins généralistes

9. Les pancréatites aiguës en réanimation pédiatrique : étude rétrospective monocentrique multi-sites française

10. Évaluation de l’impact sur l’adaptation précoce de l’antibiothérapie de la technique d’antibiogramme rapide sur milieu solide gélosé Mueller-Hinton Rapide (MHR)

11. Management of established pressure ulcer infections in spinal cord injury patients

12. Microbial-derived products as potential new antimicrobials

13. Using CRISPR-Cas systems as antimicrobials

14. Infectious encephalitis: Management without etiological diagnosis 48 hours after onset

15. Recommandations de prise en charge des encéphalites infectieuses de l’adulte

16. Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia

17. Antidiarrhoeal, antimicrobial and antioxidant effects of myrtle berries ( Myrtus communis L.) seeds extract

18. Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions

19. Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae)

20. Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona

21. Antimicrobial resistance in pathogens causing nosocomial infections in surgery and intensive care units of two hospitals in Antananarivo, Madagascar

22. Antimicrobial activity of the methanolic extracts and compounds from Vismia laurentii De Wild (Guttiferae)

23. Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction

24. Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase

25. Host-defense peptides from skin secretions of the octoploid frogs Xenopus vestitus and Xenopus wittei (Pipidae): Insights into evolutionary relationships

26. Multidisciplinary analysis of a nontoxigenic Clostridium difficile strain with stable resistance to metronidazole

27. Dexamethasone and Recombinant Human Activated Protein C Improve Myocardial Function and Efficiency During Experimental Septic Shock

28. Lactoferrin: A Multifunctional Glycoprotein Involved in the Modulation of the Inflammatory Process

29. Partial complementation of Sinorhizobium meliloti bacA mutant phenotypes by the Mycobacterium tuberculosis BacA protein

30. An immunomodulatory peptide related to frenatin 2 from skin secretions of the Tyrrhenian painted frog Discoglossus sardus (Alytidae)

31. Toward an improved structural model of the frog-skin antimicrobial peptide esculentin-1b(1-18)

32. The hymenochirins: A family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae)

33. Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns

34. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis

35. Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa

36. Virulence on the fly: Drosophila melanogaster as a model genetic organism to decipher host-pathogen interactions

37. Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae)

38. Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies

39. Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae)

40. Evidence from the primary structures of dermal antimicrobial peptides that Rana tagoi okiensis and Rana tagoi tagoi (Ranidae) are not conspecific subspecies

41. Progress in multidimensional NMR investigations of peptide and protein 3-D structures in solution. From structure to functional aspects

42. Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model

43. Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae)

44. The SOS response promotes qnrB quinolone-resistance determinant expression

45. Novel natural parabens produced by a Microbulbifer bacterium in its calcareous sponge host Leuconia nivea

46. Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis

47. [mPGES-1: it makes us sick!]

48. Evaluation of the virucidal activity of chemical disinfectants and antiseptics: the European point of view

49. [Vitamin D: skeletal and extra skeletal effects; recommendations for good practice]

50. [Polyoxometalates. A new class of inorganic CK2 inhibitors]

Catalog

Books, media, physical & digital resources